ASAN FOUNDATION
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)
- First Posted Date
- 2009-03-16
- Last Posted Date
- 2012-07-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 78
- Registration Number
- NCT00862342
- Locations
- π°π·
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients
Completed
- Conditions
- AlacrimaAchalasia
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2009-03-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT00856921
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 2
Completed
- Conditions
- Leukemia
- Interventions
- Drug: Nilotinib+mVPD
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 91
- Registration Number
- NCT00844298
- Locations
- π°π·
Daegu Fatima Hospital, Daegu, Korea, Republic of
π°π·Yeungnam University Medical Center, Daegu, Korea, Republic of
π°π·Kyungpook National University Hospital, Daegu, Korea, Republic of
Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Phase 4
Completed
- Conditions
- Helicobacter Infection
- Interventions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 199
- Registration Number
- NCT00841854
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury
Phase 4
- Conditions
- Severe SepsisSeptic ShockAcute Kidney Injury
- Interventions
- Procedure: crrt
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2009-02-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT00837057
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
Phase 1
Completed
- Conditions
- Brain and Central Nervous System TumorsLymphomaChronic Myeloproliferative DisordersMyelodysplastic/Myeloproliferative NeoplasmsUnspecified Adult Solid Tumor, Protocol SpecificLeukemiaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
- Interventions
- Biological: donor natural killer cell infusion
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT00823524
- Locations
- π°π·
University of Ulsan, Asan Medical Center, Seoul, Korea, Republic of
Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer
Phase 2
Completed
- Conditions
- Rectal Cancer
- Interventions
- Drug: Adjuvant FLDrug: Adjuvant FOLFOX
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 322
- Registration Number
- NCT00807911
- Locations
- π°π·
Seoul National Unversity Bundang Hospital, Seongnam, Korea, Republic of
π°π·National Cancer Center, Goyang, Korea, Republic of
π°π·Yeonsei University Hosptial, Seoul, Korea, Republic of
Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy
Phase 2
- Conditions
- Sarcoma
- First Posted Date
- 2008-12-11
- Last Posted Date
- 2008-12-12
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00807261
Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer
Phase 2
Completed
- Conditions
- Metastatic Pancreatic Cancer
- Interventions
- Drug: FOLFIRI.3Drug: FOLFOX
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT00786006
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Early Surgery Versus Conventional Treatment in Infective Endocarditis
Phase 4
Completed
- Conditions
- Endocarditis
- Interventions
- Procedure: Valve surgery with removal of vegetations
- First Posted Date
- 2008-09-10
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 76
- Registration Number
- NCT00750373
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
π°π·Seoul National University Hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath